Financhill
Buy
65

ALGS Quote, Financials, Valuation and Earnings

Last price:
$43.62
Seasonality move :
7.18%
Day range:
$38.13 - $43.94
52-week range:
$6.76 - $43.94
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
39.39x
P/B ratio:
3.11x
Volume:
784.9K
Avg. volume:
514.3K
1-year change:
135.07%
Market cap:
$155.6M
Revenue:
$15.5M
EPS (TTM):
-$17.11

Earnings Data

Next earnings date for ALGS
Mar 12
2025
Most recent earnings per share
-$3.07
Missed by $1.75
(Nov 6/2024)
Consensus Estimate
-$1.33
(Nov 6/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ALGS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/12/2025 Q4 $433.3K -- -- -$3.67 --
11/06/2024 Q3 $333.3K $1.3M -$3.07 -$1.33 -$1.75
08/06/2024 Q2 -- $1.1M $0.75 -$4.00 $4.75
05/07/2024 Q1 -- $986K -$5.50 -$4.75 -$0.75
03/12/2024 Q4 $1.6M $2.7M -$9.29 -$6.75 -$2.54
11/02/2023 Q3 -- -- -$10.37 -$11.88 $1.51
08/03/2023 Q2 -- -- -$10.75 -$12.38 $1.63
05/04/2023 Q1 -- -- -$13.25 -$12.13 -$1.13
03/09/2023 Q4 -- -- -$12.75 -$12.67 -$0.08
11/02/2022 Q3 -- -- -$11.00 -$14.52 $3.52
08/04/2022 Q2 -- -- -$11.75 -- --
05/04/2022 Q1 -- -- -$21.00 -- --
03/10/2022 Q4 -- -- -$22.25 -- --
11/04/2021 Q3 -- -- -$19.50 -- --
08/05/2021 Q2 -- -- -$19.75 -- --
05/10/2021 Q1 -- -- -$18.50 -- --
03/23/2021 Q4 -- -- -$27.25 -- --
11/25/2020 Q3 -- -- -$22.56 -- --
06/30/2020 Q2 -- -- -$23.71 -- --
03/31/2020 Q1 -- -- -$22.83 -- --
12/31/2019 Q4 -- -- -$20.73 -- --
09/30/2019 Q3 -- -- -$16.02 -- --

Aligos Therapeutics Earnings Questions

  • How Much did Aligos Therapeutics Generate in Revenue Last Quarter?

    Aligos Therapeutics reported $1.3M worth of top line sales in its most recent quarter.

  • Did Aligos Therapeutics Beat Earnings Last Quarter?

    Aligos Therapeutics announced earnings per share of -$3.07 which represents a miss of analyst forecast a -$1.33 per share.

  • Is Aligos Therapeutics Profitable?

    Aligos Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Aligos Therapeutics EPS Next Year?

    Aligos Therapeutics's earnings are forecast to decrease from -$34.00 per share to -$41.25 per share next year representing a decrease of -69.53%.

  • When is Aligos Therapeutics's Earnings Date?

    Aligos Therapeutics's next earnings date is March 12, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is up 49.85% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 49.62% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is up 10.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock